Sentences with phrase «on biotechnology investments»

Not exact matches

BGV III is now one of the largest funds focused on seed investments in European biotechnology companies.

Some investors don't like this watering - down of biotech exposure, while others like the idea of a slightly more diversified set of investments that still focuses heavily on biotechnology.

Investments in the NRC will generate regional economic growth on Long Island, create new jobs, and further the state's burgeoning biotechnology industries.

Sawyer also touched on R&D initiatives that draw funding for research infrastructures, and he informed the audience that biotechnology investment is introducing a new and urgent prerogative into the research equation.

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Greenbackd Portfolio, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 12, 2009 3 Comments»

Posted in Activist Investors, Biotechnology Value Fund, Highland Capital Management, Millennium Technology Value Partners, Net Cash Stocks, Neurobiological Technologies Inc (NASDAQ: NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Highland Capital Management, Liquidating Value, Millennium Technology Value Partners, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ: NTII) on February 23, 2009 5 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on February 10, 2009 1 Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 28, 2009 1 Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 2, 2009 5 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Net Net Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 17, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on February 16, 2009 1 Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 15, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Net Net Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 26, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund on March 17, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on December 24, 2008 5 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund on January 15, 2009 1 Comment»

If Biotechnology Value Fund is able to cause the company to quickly distribute the company's remaining cash to stockholders, purchasers at these levels should see a good return on investment.

Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Liquidating Value, Liquidation Value, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ: NTII) on May 11, 2009 2 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 19, 2009 2 Comments»

[Biotechnology Value Fund] believe that the investment community clearly lacks confidence in such a plan, as evidenced by recent reports from stock analysts and by the $ 0.61 per share closing price of [AVGN]'s common stock on October 30, 2008, reflecting only 31 % of [AVGN]'s financial assets as of September 30, 2008.

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 27, 2009 3 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value on May 22, 2009 2 Comments»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on August 27, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), MathStar Inc (OTC: MATH), Mill Road Capital, Nery Capital Partners, Salvatore Muoio, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), MathStar Inc (OTC: MATH), Mill Road Capital, S. Muoio & Co, Salvatore Muoio on January 7, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Northstar Neuroscience Inc (NASDAQ: NSTR), Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Northstar Neuroscience Inc (NASDAQ: NSTR), RA Capital Management on March 11, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Greenbackd Portfolio, Liquidation Value, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on July 21, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, Dolphin Limited Partnership, GAMCO, Icagen Inc (NASDAQ: ICGN), Mill Road Capital, Multimedia Games Inc (NASDAQ: MGAM), Nery Capital Partners, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), Multimedia Games Inc (NASDAQ: MGAM), Nery Capital Partners on February 10, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management on April 13, 2009 Leave a Comment»

Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on August 24, 2009 1 Comment»

Before IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies.

In addition to prosecuting patent applications on behalf of public and private institutions, biotechnology companies, and pharmaceutical companies, Dr. Rearick performs IP due diligence in a variety of in - licensing and investment contexts, with specific expertise in pharmaceuticals.

The Warsaw office of Noerr has advised PFR Life Science, a subsidiary of the Polish Development Fund, which supports infrastructure and advanced technology projects, on its PLN 38.3 million investment in Mabion S.A., a biotechnology company in Poland.